Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer

Citation
M. Sasaki et al., Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer, MOL CARCINO, 29(2), 2000, pp. 59-66
Citations number
29
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
MOLECULAR CARCINOGENESIS
ISSN journal
08991987 → ACNP
Volume
29
Issue
2
Year of publication
2000
Pages
59 - 66
Database
ISI
SICI code
0899-1987(200010)29:2<59:IOTHAR>2.0.ZU;2-3
Abstract
Androgens mediate their effects through the androgen receptor (AR) and have antiproliferative effects on uterine endometrial cells. In this report, we investigated methylation status and the expression of the AR gene in norma l endometrium and uterine endometrial cancer (UEC) tissues using methylatio n-specific polymerase chain reaction (MSP) and immunohistochemical staining . Seventy of 89 cancer samples were AR negative, although 39 of 46 normal s amples were AR positive by immunohistochemistry. By MSP, 64 of 89 cancer sa mples showed only methylated AR alleles, although all normal tissues showed both unmethylated and methylated AR alleles. To determine whether similar changes occurred in methylation status in the UEC carcinogenesis, we studie d AR methylation using pairs of cancerous and normal samples from 28 patien ts. Twenty-three of 28 cancer samples showed only methylated AR alleles, al though all normal samples showed both unmethylated and methylated alleles. All of the 23 cancer samples that lost unmethylated alleles were negative f or AR by immunohistochemical analysis. Reverse transcription-polymerase cha in reaction was performed by using UEC cell lines with and without treatmen t by the demethylating reagent 5-aza-2'-deoxycytidine. No AR expression was found in any of the UEC cell lines, except for MFE-296 without 5-aza-2'-de oxycytidine. Treatment with 5-aza-2'-deoxycytidine restored AR expression i n ail of the UEC cell lines that showed no AR expression before treatment. This study is the first to report that the possible mechanism of AR inactiv ation in endometrial cancer is through hypermethylation of the AR gene CpG islands. Mol. Carcinog. 29:59-66, 2000. (C) 2000 Wiley-Liss. Inc.